Accelerated Innovation, LLC: FDA filings under this applicant name
FDA lists 7 510(k) clearances under the applicant name “Accelerated Innovation, LLC” (first 2008, latest 2008), across 7 product codes in 1 review panel. Median 510(k) review time under this name: 96 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| JDI | Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented | 1 | 1 |
| JWH | Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer | 1 | 1 |
| KRR | Prosthesis, Knee, Patello/Femoral, Semi-Constrained, Cemented, Metal/Polymer | 1 | 1 |
| KWQ | Appliance, Fixation, Spinal Intervertebral Body | 1 | 1 |
| KWY | Prosthesis, Hip, Hemi-, Femoral, Metal/Polymer, Cemented Or Uncemented | 1 | 1 |
| LPH | Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented | 1 | 1 |
| MNH | Orthosis, Spondylolisthesis Spinal Fixation | 1 | 1 |
Review panels
- Orthopedic (7)
Most recent Accelerated Innovation, LLC 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K081127 | ACCIN TOTAL KNEE SYSTEM | JWH | 2008-10-17 | 179 |
| K080647 | ACCIN BIPOLAR HEAD SYSTEM | KWY | 2008-07-08 | 123 |
| K080539 | ACCIN UNIPOLAR HEAD SYSTEM | JDI | 2008-06-02 | 96 |
| K073120 | ACCIN PATELLOFEMORAL SYSTEM | KRR | 2008-02-29 | 116 |
| K073531 | ACCIN PEDICLE SCREW SYSTEM | MNH | 2008-02-04 | 49 |
| K073530 | ACCIN ANTERIOR CERVICAL PLATE SYSTEM | KWQ | 2008-01-31 | 45 |
| K073068 | ACCIN HIP SYSTEM | LPH | 2008-01-10 | 72 |
Recalls
openFDA lists no recalls under a recalling firm named Accelerated Innovation, LLC.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Accelerated Rehab Designs, Inc. (4 510(k)s)
- Accelerated Care Plus (3 510(k)s)
- Accelerated Care Plus (Acp) (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Accelerated Innovation, LLC?
FDA lists 7 510(k) clearances under the applicant name “Accelerated Innovation, LLC” (first 2008, latest 2008), across 7 product codes in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Accelerated Innovation, LLC?
The median time from FDA receipt to decision across 510(k)s cleared under the name Accelerated Innovation, LLC is 96 days.
Which FDA product codes appear under Accelerated Innovation, LLC?
The most frequent FDA product codes under this applicant name are JDI (Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented, 1); JWH (Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer, 1); KRR (Prosthesis, Knee, Patello/Femoral, Semi-Constrained, Cemented, Metal/Polymer, 1).
Next steps
- See all 7 Accelerated Innovation, LLC clearances with predicates and recalls
- Run predicate analysis for product code JDI, Accelerated Innovation, LLC's most frequent
Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.